High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study

T. G. Steenbruggen, L. C. Steggink, C. M. Seynaeve, J. J.M. van der Hoeven, M. J. Hooning, A. Jager, I. R. Konings, J. R. Kroep, W. M. Smit, V. C.G. Tjan-Heijnen, E. van der Wall, A. D. Bins, S. C. Linn, M. Schaapveld, F. E. van Leeuwen, C. P. Schroder, H. van Tinteren, E. G.E. de Vries, G. S. Sonke, J. A. Gietema

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)viii59
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Publication statusPublished - 1 Oct 2018

Cite this